Gene · 2195
Papers4,590
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 4,590
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms. | Front Pharmacol | 2023 | 37153758 | PubTator, text mining | PubMed |
| Integrated genomic analysis reveals aberrations in WNT signaling in germ cell tumors of childhood and adolescence. | Nat Commun | 2023 | 37149691 | PubTator, text mining | PubMed |
| Oncogenic signaling-mediated regulation of chromatin during tumorigenesis. | Cancer Metastasis Rev | 2023 | 37147457 | PubTator, text mining | PubMed |
| KK-LC-1 as a therapeutic target to eliminate ALDH+ stem cells in triple negative breast cancer. | Nat Commun | 2023 | 37147285 | PubTator, text mining | PubMed |
| Clinical features and molecular genetics associated with brain metastasis in suspected early-stage non-small cell lung cancer. | Front Oncol | 2023 | 37139160 | PubTator, text mining | PubMed |
| The Genomic Landscape of Vulvar Squamous Cell Carcinoma. | Int J Gynecol Pathol | 2023 | 37131274 | PubTator, text mining | PubMed |
| Genomic and transcriptomic features between primary and paired metastatic fumarate hydratase-deficient renal cell carcinoma. | Genome Med | 2023 | 37131267 | PubTator, text mining | PubMed |
| Prognostic and Immunological Significance of the Molecular Subtypes and Risk Signatures Based on Cuproptosis in Hepatocellular Carcinoma. | Mediators Inflamm | 2023 | 37124062 | PubTator, text mining | PubMed |
| The role of the genomic mutation signature and tumor mutation burden on relapse risk prediction in head and neck squamous cell carcinoma after concurrent chemoradiotherapy. | Exp Mol Med | 2023 | 37121970 | PubTator, text mining | PubMed |
| Regulation of Sertoli cell function by planar cell polarity (PCP) protein Fjx1. | Mol Cell Endocrinol | 2023 | 37119967 | PubTator, text mining | PubMed |
| DNA-PKcs as an upstream mediator of OCT4-induced MYC activation in small cell lung cancer. | Biochim Biophys Acta Gene Regul Mech | 2023 | 37116859 | PubTator, text mining | PubMed |
| Clinically relevant glioblastoma patient-derived xenograft models to guide drug development and identify molecular signatures. | Front Oncol | 2023 | 37114125 | PubTator, text mining | PubMed |
| Predictive Biomarkers for Immune-Checkpoint Inhibitor Treatment Response in Patients with Hepatocellular Carcinoma. | Int J Mol Sci | 2023 | 37108802 | PubTator, text mining | PubMed |
| Glycemia-Induced miRNA Changes: A Review. | Int J Mol Sci | 2023 | 37108651 | PubTator, text mining | PubMed |
| Glioblastoma Microenvironment and Invasiveness: New Insights and Therapeutic Targets. | Int J Mol Sci | 2023 | 37108208 | PubTator, text mining | PubMed |
| Fat and Dachsous cadherins in mammalian development. | Curr Top Dev Biol | 2023 | 37100519 | PubTator, text mining | PubMed |
| The adaptive evolution of cancer driver genes. | BMC Genomics | 2023 | 37098512 | PubTator, text mining | PubMed |
| Antiparallel dimer structure of CELSR cadherin in solution revealed by high-speed atomic force microscopy. | Proc Natl Acad Sci U S A | 2023 | 37094146 | PubTator, text mining | PubMed |
| Mutations Status of NOTCH Signaling Pathway Predict Prognosis of Immune Checkpoint Inhibitors in Colorectal Cancer. | J Inflamm Res | 2023 | 37092128 | PubTator, text mining | PubMed |
| Identification and verification of prognostic cancer subtype based on multi-omics analysis for kidney renal papillary cell carcinoma. | Front Oncol | 2023 | 37091151 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2195/papers?page=38